The fall IPO market kept a brisk pace this past week with 11 IPOs, led by restaurant chain Portillo’s (PTLO). SPACs also stayed active, with 18 blank check IPOs. There was one postponement: winery Winc (WBEV). New filers continue to...read more
Xilio Therapeutics, a Phase 1 biotech developing novel molecules to treat solid tumors, raised $118 million by offering 7.4 million shares at $16, the low end of the range of $16 to $18. Xilio has built its geographically precise solutions (GPS) platform to...read more
Xilio Therapeutics, a Phase 1 biotech developing novel molecules to treat solid tumors, announced terms for its IPO on Monday. The Waltham, MA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the...read more
The IPO market remained active this past week as four IPOs raised $2.3 billion, joined by two direct listings. SPAC activity kept steady with nine blank check IPOs. New filers continue to pour into the IPO pipeline, with 17 IPOs and 10 SPACs submitting initial...read more
US IPO Weekly Recap: Portillo’s gains 87% in an 11 IPO week
The fall IPO market kept a brisk pace this past week with 11 IPOs, led by restaurant chain Portillo’s (PTLO). SPACs also stayed active, with 18 blank check IPOs. There was one postponement: winery Winc (WBEV). New filers continue to...read more
Solid tumor biotech Xilio Therapeutics prices IPO at $16 low end
Xilio Therapeutics, a Phase 1 biotech developing novel molecules to treat solid tumors, raised $118 million by offering 7.4 million shares at $16, the low end of the range of $16 to $18. Xilio has built its geographically precise solutions (GPS) platform to...read more
Solid tumor biotech Xilio Therapeutics sets terms for $125 million IPO
Xilio Therapeutics, a Phase 1 biotech developing novel molecules to treat solid tumors, announced terms for its IPO on Monday. The Waltham, MA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the...read more
US IPO Weekly Recap: The IPO market can see clearly now in a 4 IPO, 2 direct listing week
The IPO market remained active this past week as four IPOs raised $2.3 billion, joined by two direct listings. SPAC activity kept steady with nine blank check IPOs. New filers continue to pour into the IPO pipeline, with 17 IPOs and 10 SPACs submitting initial...read more